236 related articles for article (PubMed ID: 33303370)
1. Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
Murata T; Watase C; Shiino S; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
Clin Breast Cancer; 2021 Aug; 21(4):e302-e311. PubMed ID: 33303370
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
[TBL] [Abstract][Full Text] [Related]
3. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
Samiei S; van Nijnatten TJA; van Beek HC; Polak MPJ; Maaskant-Braat AJG; Heuts EM; van Kuijk SMJ; Schipper RJ; Lobbes MBI; Smidt ML
Sci Rep; 2019 Nov; 9(1):17476. PubMed ID: 31767929
[TBL] [Abstract][Full Text] [Related]
5. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
6. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a nomogram prediction model for axillary lymph node metastasis of cT1 invasive breast cancer.
Wang S; Wang D; Wen X; Xu X; Liu D; Tian J
Eur J Cancer Prev; 2024 Jul; 33(4):309-320. PubMed ID: 37997911
[TBL] [Abstract][Full Text] [Related]
8. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
[TBL] [Abstract][Full Text] [Related]
10. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer.
Abe H; Schacht D; Sennett CA; Newstead GM; Schmidt RA
AJR Am J Roentgenol; 2013 Mar; 200(3):696-702. PubMed ID: 23436865
[TBL] [Abstract][Full Text] [Related]
11. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.
Yu Y; Wang Z; Wei Z; Yu B; Shen P; Yan Y; You W
BMC Cancer; 2021 Apr; 21(1):466. PubMed ID: 33902502
[TBL] [Abstract][Full Text] [Related]
13. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?
Neal CH; Daly CP; Nees AV; Helvie MA
Radiology; 2010 Nov; 257(2):335-41. PubMed ID: 20807849
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
15. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
[TBL] [Abstract][Full Text] [Related]
16. A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasound.
Meretoja TJ; Heikkilä PS; Mansfield AS; Cserni G; Ambrozay E; Boross G; Zgajnar J; Perhavec A; Gazic B; Arisio R; Tvedskov TF; Jensen MB; Leidenius MH
Ann Surg Oncol; 2014 Jul; 21(7):2229-36. PubMed ID: 24664623
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study.
Noda S; Onoda N; Asano Y; Kurata K; Tokumoto M; Morisaki T; Kashiwagi S; Takashima T; Hirakawa K
Int J Surg; 2016 Feb; 26():1-5. PubMed ID: 26700202
[TBL] [Abstract][Full Text] [Related]
18. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
Orozco JIJ; Le J; Ensenyat-Mendez M; Baker JL; Weidhaas J; Klomhaus A; Marzese DM; DiNome ML
Ann Surg Oncol; 2022 Oct; 29(10):6407-6414. PubMed ID: 35842534
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
Dihge L; Bendahl PO; Rydén L
Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
